Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-08-30

Clinical Trial Update: Glucocorticoids Promote Osteoclast Survival

View source ↗

Summary

A University of Arkansas study investigating glucocorticoids' effect on osteoclast survival in osteoporosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Arkansas | Conditions: Osteoporosis | Status: TERMINATED